Editorial Board
Editors-in-Chief
Darren Brenner
University of Calgary, Calgary, Canada
Interests: Cancer Epidemiology;Molecular Epidemiology;Cancer Screening;Cancer Outcomes Research
Oliver Schnell
Department of Neurosurgery, Medical Center, University of Freiburg, 79106 Freiburg, Germany
Interests: neurooncology; CNS tumors; glioma; ependymoma; meningioma; brain and spinal metastasis;
Wolfgang Link
Department of Cancer Biology, Instituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), 28029 Madrid, Spain
Interests: cancer signaling; cancer therapy resistance;
Lorenzo Lo Muzio
Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy
Interests: oral cancer; cancer stem cell;
Michaela Luconi
Department of Experimental and Clinical Biomedical Sciences, Endocrinology Unit, University of Florence, I‐50139 Florence, Italy
Interests: adrenal tumors; molecular and cell biology of endocrine tumors and metabolic pathologies
Enzo Medico
University of Torino and Candiolo Cancer Institute, FPO-IRCCS, Str. Prov. 142, km 3.95, 10060 Candiolo (TO), Italy
Interests: oncogenomics; colorectal cancer; breast cancer; tumor microenvironment; precision medicine; preclinical oncology
Markku Miettinen
Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA
Interests: gastrointestinal stromal tumor; sarcoma; smooth muscle tumors; vascular tumors; neurofibromatosis; fusion tumors
Subhadip Mukhopadhyay
Biotechnology Department, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India
Interests: cancer; autophagy; apoptosis; cell biology; metabolism; therapy resistance
Shaun A. Nguyen
Department of Otolaryngology—Head and Neck Surgery, Medical University of South Carolina, 135 Rutledge Avenue, MSC550, Charleston, SC 29425, USA
Interests: otolaryngology; head and neck cancer
Tadeusz Pawełczyk
Department of Molecular Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland
Interests: tumor development; colon cancer; signaling pathways; gene regulation; drug resistance; purine receptors; molecular markers of cancer
Avery D. Posey
Department of Systems Pharmacology and Translational Therapeutics and Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Interests: cancer immunotherapy; tumor microenvironment; immune exhaustion; tumor glycosylation; neoantigens
Back to top
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept